XML 17 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Financial Condition - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Assets    
Cash and cash equivalents ($4.3 million restricted from use at March 31, 2017 and December 31, 2016) $ 51,993 $ 98,313
Advisory fees receivable, net of allowance for doubtful accounts of $0.0 million at March 31, 2017 and December 31, 2016 67,557 68,140
Other receivables 6,066 2,830
Property and equipment, net of accumulated depreciation of $59.5 million at March 31, 2017 and $59.0 million at December 31, 2016 8,605 8,764
Goodwill 214,335 208,186
Deferred tax asset, net 53,477 62,108
Other assets 8,122 8,341
Total assets 410,155 456,682
Liabilities and Equity    
Compensation payable 15,228 37,527
Accounts payable and accrued expenses 9,189 9,297
Current income taxes payable 2,774 18,968
Bank revolving loan payable 74,000 64,070
Bank term loans payable 16,875 16,875
Contingent obligation due selling unitholders of Cogent 9,090 15,095
Deferred tax liability 4,022 3,667
Total liabilities 131,178 165,499
Common stock, par value $0.01 per share; 100,000,000 shares authorized, 42,394,661 and 41,377,614 shares issued as of March 31, 2017 and December 31, 2016, respectively; 29,574,680 and 28,981,189 shares outstanding as of March 31, 2017 and December 31, 2016, respectively 424 414
Restricted stock units 58,519 85,907
Additional paid-in capital 773,999 734,728
Exchangeable shares of subsidiary; 257,156 shares issued as of March 31, 2017 and December 31, 2016; 32,804 shares outstanding as of March 31, 2017 and December 31, 2016 1,958 1,958
Retained earnings 95,599 111,798
Accumulated other comprehensive income (loss) (27,782) (32,398)
Treasury stock, at cost, par value $0.01 per share; 12,819,981 and 12,396,425 shares as of March 31, 2017 and December 31, 2016, respectively (623,740) (611,224)
Stockholders’ equity 278,977 291,183
Total liabilities and equity $ 410,155 $ 456,682